BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38109544)

  • 41. Detection and measurement of paracaspase MALT1 activity.
    Hailfinger S; Pelzer C; Thome M
    Methods Mol Biol; 2014; 1133():177-88. PubMed ID: 24567102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
    Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
    Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
    Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
    Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.
    Dai B; Grau M; Juilland M; Klener P; Höring E; Molinsky J; Schimmack G; Aukema SM; Hoster E; Vogt N; Staiger AM; Erdmann T; Xu W; Erdmann K; Dzyuba N; Madle H; Berdel WE; Trneny M; Dreyling M; Jöhrens K; Lenz P; Rosenwald A; Siebert R; Tzankov A; Klapper W; Anagnostopoulos I; Krappmann D; Ott G; Thome M; Lenz G
    Blood; 2017 Jan; 129(3):333-346. PubMed ID: 27864294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.
    Staal J; Driege Y; Bekaert T; Demeyer A; Muyllaert D; Van Damme P; Gevaert K; Beyaert R
    EMBO J; 2011 May; 30(9):1742-52. PubMed ID: 21448133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
    Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
    Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.
    Zhang YY; Peng J; Luo XJ
    Biochem Pharmacol; 2022 Apr; 198():114977. PubMed ID: 35218741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
    Bardet M; Unterreiner A; Malinverni C; Lafossas F; Vedrine C; Boesch D; Kolb Y; Kaiser D; Glück A; Schneider MA; Katopodis A; Renatus M; Simic O; Schlapbach A; Quancard J; Régnier CH; Bold G; Pissot-Soldermann C; Carballido JM; Kovarik J; Calzascia T; Bornancin F
    Immunol Cell Biol; 2018 Jan; 96(1):81-99. PubMed ID: 29359407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.
    Kloo B; Nagel D; Pfeifer M; Grau M; Düwel M; Vincendeau M; Dörken B; Lenz P; Lenz G; Krappmann D
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):272-7. PubMed ID: 21173233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
    Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ
    Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MALT1 protease: a new therapeutic target in B lymphoma and beyond?
    McAllister-Lucas LM; Baens M; Lucas PC
    Clin Cancer Res; 2011 Nov; 17(21):6623-31. PubMed ID: 21868762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
    Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
    Front Immunol; 2018; 9():1136. PubMed ID: 29881386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
    Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
    J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.
    Schmitt A; Grondona P; Maier T; Brändle M; Schönfeld C; Jäger G; Kosnopfel C; Eberle FC; Schittek B; Schulze-Osthoff K; Yazdi AS; Hailfinger S
    J Invest Dermatol; 2016 Apr; 136(4):788-797. PubMed ID: 26767426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Paracaspase MALT1.
    Hachmann J; Salvesen GS
    Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
    Nicolau CA; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104115. PubMed ID: 32388054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
    Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
    J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assignment of IVL-Methyl side chain of the ligand-free monomeric human MALT1 paracaspase-IgL
    Han X; Levkovets M; Lesovoy D; Sun R; Wallerstein J; Sandalova T; Agback T; Achour A; Agback P; Orekhov VY
    Biomol NMR Assign; 2022 Oct; 16(2):363-371. PubMed ID: 36094731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
    McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
    Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
    Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
    PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.